These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 14558329

  • 1. [Spanish survey on anaemia management].
    Pérez García R.
    Nefrologia; 2003; 23(4):300-11. PubMed ID: 14558329
    [Abstract] [Full Text] [Related]

  • 2. [Anemia management in haemodialysis. EuCliD database in Spain].
    Avilés B, Coronel F, Pérez-García R, Marcelli D, Orlandini G, Ayala JA, Rentero R.
    Nefrologia; 2002; 22(6):555-63. PubMed ID: 12516289
    [Abstract] [Full Text] [Related]

  • 3. Results of the European Survey on Anaemia Management 2003 (ESAM 2003): current status of anaemia management in dialysis patients, factors affecting epoetin dosage and changes in anaemia management over the last 5 years.
    Jacobs C, Frei D, Perkins AC.
    Nephrol Dial Transplant; 2005 May; 20 Suppl 3():iii3-24. PubMed ID: 15824128
    [Abstract] [Full Text] [Related]

  • 4. Renal anemia: comparing current Eastern and Western European management practice (ORAMA).
    Wiecek A, Covic A, Locatelli F, Macdougall IC, ORAMA study group.
    Ren Fail; 2008 May; 30(3):267-76. PubMed ID: 18350446
    [Abstract] [Full Text] [Related]

  • 5. ORAMA: a study to investigate EBPG impact on renal anaemia - design and baseline data.
    Locatelli F, Covic A, Macdougall IC, Wiecek A, ORAMA Study Group.
    J Nephrol; 2008 May; 21(4):592-603. PubMed ID: 18651551
    [Abstract] [Full Text] [Related]

  • 6. Optimal treatment of renal anaemia (OPTA): improving the efficacy and efficiency of renal anaemia therapy in haemodialysis patients receiving intravenous epoetin.
    Hörl WH, Vanrenterghem Y, Canaud B, Mann J, Teatini U, Wanner C, Wikström B.
    Nephrol Dial Transplant; 2005 May; 20 Suppl 3():iii25-32. PubMed ID: 15824127
    [Abstract] [Full Text] [Related]

  • 7. Mineral metabolism and haemoglobin concentration among haemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Kimata N, Akiba T, Pisoni RL, Albert JM, Satayathum S, Cruz JM, Akizawa T, Andreucci VE, Young EW, Port FK.
    Nephrol Dial Transplant; 2005 May; 20(5):927-35. PubMed ID: 15728270
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
    Wizemann V, Rutkowski B, Baldamus C, Scigalla P, Koytchev R, Epoetin Zeta Study Group.
    Curr Med Res Opin; 2008 Mar; 24(3):625-37. PubMed ID: 18208642
    [Abstract] [Full Text] [Related]

  • 9. Switching from subcutaneous to intravenous erythropoietin alpha in haemodialysis patients requires a major dose increase.
    Galliford JW, Malasana R, Farrington K.
    Nephrol Dial Transplant; 2005 Sep; 20(9):1956-62. PubMed ID: 15930017
    [Abstract] [Full Text] [Related]

  • 10. Proposed therapeutic algorithm for the treatment of anemia of chronic renal failure in pre-dialysis patients with low dose once weekly subcutaneous r-HuEPO. Multicenter Study Group, Israel.
    Yagil Y.
    Isr J Med Sci; 1997 Jan; 33(1):36-44. PubMed ID: 9203516
    [Abstract] [Full Text] [Related]

  • 11. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis.
    Coronel F, Herrero JA, Montenegro J, Fernandez C, Gandara A, Conesa J, Rivera MT, Torrente J, Portolés J, Gomez-Martino JR.
    J Nephrol; 2003 Jan; 16(5):697-702. PubMed ID: 14733416
    [Abstract] [Full Text] [Related]

  • 12. [Single weekly dose of recombinant erythropoietin in children with chronic renal insufficiency].
    Guízar JM, Gutiérrez MJ, Sánchez G, Kornhauser C.
    Rev Invest Clin; 1996 Jan; 48(3):173-7. PubMed ID: 8966377
    [Abstract] [Full Text] [Related]

  • 13. Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia.
    Marsillach J, Martínez-Vea A, Marcas L, Mackness B, Mackness M, Ferré N, Joven J, Camps J.
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):347-9. PubMed ID: 17324148
    [Abstract] [Full Text] [Related]

  • 14. Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients.
    Mircescu G, Gârneata L, Capusa C, Ursea N.
    Nephrol Dial Transplant; 2006 Jan; 21(1):120-4. PubMed ID: 16144853
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of intravenous methoxy polyethylene glycol-epoetin beta administered every 2 weeks compared with epoetin administered 3 times weekly in patients treated by hemodialysis or peritoneal dialysis: a randomized trial.
    Klinger M, Arias M, Vargemezis V, Besarab A, Sulowicz W, Gerntholtz T, Ciechanowski K, Dougherty FC, Beyer U.
    Am J Kidney Dis; 2007 Dec; 50(6):989-1000. PubMed ID: 18037099
    [Abstract] [Full Text] [Related]

  • 16. Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly.
    Sulowicz W, Locatelli F, Ryckelynck JP, Balla J, Csiky B, Harris K, Ehrhard P, Beyer U, PROTOS Study Investigators.
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):637-46. PubMed ID: 17699476
    [Abstract] [Full Text] [Related]

  • 17. The efficacy and safety of once-weekly and once-fortnightly subcutaneous epoetin beta in peritoneal dialysis patients with chronic renal anaemia.
    Grzeszczak W, Sulowicz W, Rutkowski B, de Vecchi AF, Scanziani R, Durand PY, Bajo A, Vargemezis V, European Collaborative Group.
    Nephrol Dial Transplant; 2005 May; 20(5):936-44. PubMed ID: 15769814
    [Abstract] [Full Text] [Related]

  • 18. [Therapy of renal anemia with recombinant human erythropoietin].
    Schaefer RM, Kürner B, Zech M, Krahn R, Heidland A.
    Dtsch Med Wochenschr; 1988 Jan 29; 113(4):125-9. PubMed ID: 3276487
    [Abstract] [Full Text] [Related]

  • 19. Anaemia and mortality in haemodialysis patients: interaction of propensity score for predicted anaemia and actual haemoglobin levels.
    Roberts TL, Foley RN, Weinhandl ED, Gilbertson DT, Collins AJ.
    Nephrol Dial Transplant; 2006 Jun 29; 21(6):1652-62. PubMed ID: 16449283
    [Abstract] [Full Text] [Related]

  • 20. [Is the management of anemia in hemodialysis patients improving in France? Results of the DiaNE study].
    Kessler M, Landais P, Canivet E, Yver L, Bataille P, Brillet G, Commenges B, Koné S.
    Nephrol Ther; 2009 Apr 29; 5(2):114-21. PubMed ID: 19042175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.